DRTS Alpha Tau Medical Ltd. Ordinary Shares Surgical & Medical Instruments & Apparatus Best Medical Devices Stocks 2026 →

DRTS Stock Analysis: Buy, Sell, or Hold?

$14.02
+0.32 (+2.34%) ▲
5d: -0.07% 30d: +2.04% 90d: -3.31%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (26%)
Quality Score
42/100
Position
EXTENDED
30-Day Fair Range
$12.95 – $14.19
Position: EXTENDED
Forward P/E & Valuation
-26.2x
Next 12M consensus est.
Wall Street Target
$17.80
+27.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$12.67 / $14.59
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: DRTS shows conflicting indicators. Wait for confirmation before entering.
Smart Money Distribution

Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →

Signal fired Nov 5, 2026 at $13.34 · last confirmed Nov 9, 2026

Strength: 5.6/10

Get Alerted When DRTS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: DRTS is currently trading at $14.02, which is considered extended relative to its 30-day fair value range of $12.95 to $14.19.

Technical Outlook: Technically, DRTS is in a uptrend. Immediate support is located at $12.67, while resistance sits at $14.59.

Market Sentiment: DRTS scores 23/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $17.80 (+27.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $12.95 - $14.19
Company Quality Score 42/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 26.3%

Trading Range & Key Levels

30-Day Trading Range $12.95 - $14.19
Current vs Trading Range EXTENDED
Support Level $12.67
Resistance Level $14.59
Current Trend Uptrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BEARISH: Price extended above range
  • BEARISH: Weak technical setup (23/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 27.0% below Wall St target ($17.80)
  • WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -26.23
Wall Street Target $17.80 (+27.0%)
Share DRTS Analysis

Share this live DRTS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (DRTS)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary: Mercury Systems and Alpha Tau were upgraded by analysts, while Nvidia was downgraded in the latest research calls. Mercury Systems was upgraded due to strong Q3 performance, while the potential of Alpha DaRT technology was highlighted for Alpha Tau.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:06 AM ET
Data refreshes hourly during market hours. Next update: 8:06 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for DRTS.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ALNY
Alnylam Pharmaceuticals …
STRONG BUY
30 analysts
$302 55 HOLD
IONS
Ionis Pharmaceuticals Inc
STRONG BUY
25 analysts
$84 50 HOLD
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 50 HOLD
TVTX
Travere Therapeutics Inc
STRONG BUY
15 analysts
$75 66 BUY
GPCR
Structure Therapeutics I…
STRONG BUY
16 analysts
$107 50 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive DRTS Research Pages
DRTS Technical Chart DRTS Price Prediction DRTS Intrinsic Value DCF DRTS Earnings Date Why is DRTS Moving Today? DRTS Investment Advisor DRTS Fair Price Analyzer DRTS Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals